» Articles » PMID: 31300050

Immune Cell Concentrations Among the Primary Tumor Microenvironment in Colorectal Cancer Patients Predicted by Clinicopathologic Characteristics and Blood Indexes

Overview
Date 2019 Jul 14
PMID 31300050
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Immune cells play a key role in cancer progression and treatment. It is unclear whether the clinicopathologic characteristics and blood indexes of colorectal cancer (CRC) patients could predict immune cell concentrations in the tumor microenvironment.

Methods: CRC patients with detailed data and tumor tissue who visited Sun Yat-sen University Cancer Center between April 1, 2004, and September 1, 2017, were enrolled. The densities of CD3+ and CD8+ T cells examined by immunohistochemistry in both the core of the tumor (CT) and the invasive margin (IM) were summed as the Immunoscore. The relationships between the Immunoscore and clinicopathologic characteristics and blood indexes, including tumor biomarkers (carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9)), inflammatory markers (lactate dehydrogenase (LDH), C-reactive protein (CRP), albumin (ALB), neutrophils, lymphocytes, monocytes, platelets, NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio) and LMR (lymphocyte-to-monocyte ratio)) and lipid metabolism markers (cholesterol (CHO), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein A1 (ApoA1), and apolipoprotein B (ApoB)), were analyzed using SPSS.

Results: Older patients had lower CD3+ and CD8+ T cell expression in the IM and a lower Immunoscore than did younger patients. CD8+ T cell expression in the IM and the Immunoscore were lower in right-side tumors than in left-sided tumors. High CD8+ T cell expression in the CT was found in the T4 stage group. The higher the CEA level in the blood, the fewer CD8+ T cells were in the CT. Either fewer monocytes or a higher LMR in the blood, the larger number of CD3+ T cells in the CT. The more ApoA1 was in the blood, the more CD3+ T cells were in both the CT and the IM.

Conclusion: Age, T stage, tumor location, CEA, monocytes, LMR and ApoA1 could reflect immune cells infiltrating the tumor microenvironment of CRC.

Citing Articles

Tertiary lymphoid structures in colorectal cancer - organization and immune cell interactions.

Gulubova M, Valkanov S, Ignatova M, Minkov G Am J Clin Exp Immunol. 2025; 13(6):236-245.

PMID: 39839346 PMC: 11744347. DOI: 10.62347/GRYY2849.


A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients.

Chen S, Chang W, Zhang J, Liu X, Gao T, Qi X J Inflamm Res. 2024; 17:11587-11604.

PMID: 39737097 PMC: 11683201. DOI: 10.2147/JIR.S489432.


Exploring the Role of Genetic and Environmental Features in Colorectal Cancer Development: An Agent-Based Approach.

Ledda M, Pluchino A, Ragusa M Entropy (Basel). 2024; 26(11).

PMID: 39593869 PMC: 11593013. DOI: 10.3390/e26110923.


New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis.

Khanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R BJC Rep. 2024; 2(1):37.

PMID: 39516662 PMC: 11523988. DOI: 10.1038/s44276-024-00056-8.


Association between CT-based adipose variables, preoperative blood biochemical indicators and pathological T stage of clear cell renal cell carcinoma.

Sun Z, Zhang Y, Xia Y, Ba X, Zheng Q, Liu J Heliyon. 2024; 10(2):e24456.

PMID: 38268833 PMC: 10803934. DOI: 10.1016/j.heliyon.2024.e24456.


References
1.
Hammarstrom S . The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999; 9(2):67-81. DOI: 10.1006/scbi.1998.0119. View

2.
Provinciali M, Argentati K, Tibaldi A . Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther. 2000; 7(7):624-32. DOI: 10.1038/sj.gt.3301131. View

3.
Weitz J, Koch M, Debus J, Hohler T, Galle P, Buchler M . Colorectal cancer. Lancet. 2005; 365(9454):153-65. DOI: 10.1016/S0140-6736(05)17706-X. View

4.
Condeelis J, Pollard J . Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124(2):263-6. DOI: 10.1016/j.cell.2006.01.007. View

5.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View